Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial. J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s17. Available from: https://skin.dermsquared.com/skin/article/view/1170